melanocortin receptor comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-12-22. Where a claim depends on a specific study, the study is described rather than over-claimed.
Melanotan-2 is a synthetic cyclic heptapeptide designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous tridecapeptide that regulates pigment production. Two modifications distinguish it from the natural hormone: norleucine replaces methionine at the N-terminus, which limits oxidation, and a D-phenylalanine substitution raises receptor affinity. The ring is closed through an aspartate-lysine lactam bridge, giving the molecule a constrained conformation. The free base has a molecular mass near 1024 daltons, and commercial material is usually supplied as an acetate salt. It appears in the literature as a research peptide rather than an approved therapeutic agent.
Receptor studies place melanotan-2 among non-selective melanocortin agonists, binding MC1R, MC3R, MC4R and MC5R rather than a single subtype. Activation of MC1R on cutaneous melanocytes raises tyrosinase activity and shifts pigment synthesis toward eumelanin, which is darker and more photostable than pheomelanin. Central receptors, particularly MC4R, are associated with appetite suppression and with reported effects on sexual function. Because subtype selectivity is low, the same molecule engages pigment, metabolic and vascular pathways at once, and this breadth is a common explanation offered for the range of adverse events described in user reports.
No regulatory authority has approved melanotan-2 for human use, and several countries classify it as a prescription-only or controlled substance, which restricts lawful supply. Material sold online is generally labelled as a research chemical and is not required to meet pharmaceutical standards of identity or purity. Published human data consist mainly of small uncontrolled studies, case reports and adverse-event notifications, so the evidence base is descriptive rather than confirmatory. Whether repeated melanocyte stimulation alters long-term naevus behaviour remains an open question that no completed trial has resolved.
Solid peptide material is generally stable when kept cold and dry. Common practice is storage at -20 degrees Celsius or lower, with desiccant and protection from light. Repeated freeze-thaw cycles and exposure to moisture are associated with degradation, aggregation, or loss of material. Once dissolved, stability depends on solvent, concentration, and temperature, and solutions are usually treated as short-lived unless stability data support longer periods. Handling notes typically emphasise minimising time at ambient temperature.
Identity and purity are assessed with chromatographic and mass spectrometric techniques. Reversed-phase high-performance liquid chromatography separates the target peptide from related impurities and degradation products, and the resulting retention time is compared against a reference standard. Mass spectrometry, often coupled to liquid chromatography, confirms molecular mass. Amino acid analysis or peptide mapping can provide additional sequence-level confirmation when required. Results are only as reliable as the reference materials used alongside them.
Regulatory treatment varies by country. In the United States, melanotan-2 is not approved for any indication, and products marketed for human use fall outside the approved drug framework. Some other jurisdictions have placed it under prescription controls or listed it as a prohibited or restricted substance. Online listings frequently describe the material as a research chemical, a category that does not carry the same manufacturing and labelling requirements as approved medicines.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C50H69N15O9 | Free base; salt forms add to total mass |
| Molecular mass | About 1024 daltons | Calculated for the free base |
| Structural class | Cyclic heptapeptide | Contains D-phenylalanine and norleucine |
| Parent hormone | Alpha-melanocyte-stimulating hormone | Endogenous tridecapeptide of 13 residues |
| Receptor profile | Non-selective melanocortin agonist | Interacts with MC1R, MC3R, MC4R and MC5R |
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence incorporates a lactam bridge that constrains the peptide into a ring, which increases resistance to enzymatic breakdown relative to the natural hormone. Researchers at the University of Arizona synthesised the compound in the late 1980s and early 1990s while studying pigmentation pathways. It has never received marketing approval from any national medicines regulator. In the scientific literature it is usually described as a laboratory research reagent rather than a therapeutic product.
The peptide acts as a non-selective agonist at melanocortin receptors, showing affinity for MC1R, MC3R, MC4R and MC5R. Activation of MC1R on melanocytes drives the conversion of tyrosine into melanin and shifts production toward the darker eumelanin form. MC4R signalling in the central nervous system is linked to appetite and energy balance, which helps explain why reduced food intake appeared in early human studies. Effects on MC4R and on vascular tone also account for the erectile responses recorded as unexpected findings in those same trials.
Identity testing for a synthetic peptide relies on several complementary methods. Reversed-phase high-performance liquid chromatography separates the target from related impurities and reports purity as a percentage of total peak area. Mass spectrometry confirms molecular mass and can reveal deletions or truncations. Amino acid analysis and peptide mapping provide sequence-level confirmation, while counter-ion content and residual solvents are measured separately. A purity figure alone does not establish identity, so a complete dataset combines chromatographic and spectrometric evidence.
Lyophilized peptide powder is generally stored frozen, protected from light and moisture. Tryptophan residues are susceptible to oxidation, and the lactam bridge can hydrolyze under strongly acidic or basic conditions. Solutions prepared for laboratory work degrade faster than dry powder, and repeated freeze-thaw cycles accelerate loss. Common practice is to aliquot solutions before freezing and to avoid alkaline buffers. Reported stability windows vary with concentration, buffer, and temperature, so exact shelf lives are method-specific rather than universal.
=== Granulation === Granulation tissue is the perfused, fibrous connective tissue that replaces a fibrin clot in healing wounds. It typically grows from the base of a wound and is able to fill wounds of almost any size as it heals. HA is abundant in granulation tissue matrix. A variety of cell functions that are essential for tissue repair may attribute to this HA-rich network. These functions include facilitation of cell migration into the provisional wound matrix, cell proliferation, and organization of the granulation tissue matrix. Initiation of inflammation is crucial for the formation of granulation tissue; therefore, the pro-inflammatory role of HA as discussed above also contributes to this stage of wound healing.
== Instrumentation == In DESI, there is a high-velocity pneumatically assisted electrospray jet that is continually directed towards the probe surface. The jet forms a micrometer-size thin solvent film on the sample where it can be desorbed. The sample can be dislodged by the incoming spray jet allowing for particles to come off in an ejection cone of analyte containing secondary ion droplets. A lot of study is still going into looking at the working principals of DESI but there are still some things known. The erosion diameter of the spray spot formed by DESI is known to be directly tied to the spatial resolution. Both the chemical composition and the texture of the surface will also affect the ionization process. The nebulizing gas used most commonly is N2 set at a typical pressure of 160 psi. The solvent is a combination of methanol and water, sometimes paired with 0.5% acetic acid and at a flow rate of 10 μL/min. The surface can be mounted it two different ways, one way consists of a surface holder that can carry 1 x 5 cm large disposable surface slides that lie on a stainless steel surface. The steel surface has a voltage applied to provide an appropriate surface potential. The surface potential that can be applied is the same at which the sprayer can be set at. The second surface is made with an aluminum block that has a built in heater, this allows for temperature control with temperatures up to 300 °C with newer stages having built in CCD's and light sources. Their spectra are that similar to ESI.
== University presidents and administrators == John M. Mason (1789), provost of Columbia College and president of Dickinson College Philip Milledoler (1793), fifth president of Rutgers University Nathaniel Fish Moore (1802), eighth President of Columbia University Isaac Ferris (1816), third president of New York University James Hall Mason Knox (1841), 8th president of Lafayette College John Aikman Stewart (1841), businessman, banker, acting president of Princeton University John Howard Van Amringe (1860), mathematician and dean of Columbia College Seth Low (1870), president of Columbia University and mayor of New York City Nicholas Murray Butler (1882), president of Columbia University, chairman of the Carnegie Endowment for International Peace and Nobel Peace Prize winner, founder of Horace Mann School and the College Board Francis Lister Hawks Pott (1883), Episcopal missionary and president of St. John's University, Shanghai 1888–1941 Thomas Fiske (1885), professor of mathematics at Columbia University; acting dean of Barnard College; president of the American Mathematical Society 1902–1904; secretary of the College Board Frank Pierrepont Graves (1890), former president of the University of Washington, University of Wyoming; commissioner of Education of the State of New York 1921–1940 Frank D. Fackenthal (1906), acting president of Columbia University Dixon Ryan Fox (1911), Union College president 1934–1945 Louis L.
Sources: en.wikipedia.org
DiCaprio is regarded as one of the finest actors of his generation. In a 2022 readers' poll by Empire, he was voted one of the 50 greatest actors of all time. The magazine praised his willingness to "go to the ends of the earth (often literally) to get under his characters' skin". Colin Covert of The Seattle Times similarly believed DiCaprio "redefines film stardom" through his willingness to take on challenging roles that few of his contemporaries are capable of performing. Since his international stardom with Titanic (1997), he has admitted feeling nervous about starring in big-budget studio films because of their hype and marketing campaigns. As an actor, he views film as a "relevant art form, like a painting or sculpture. A hundred years from now, people will still be watching that movie." He often plays roles based on real-life people and stories told in specific periods. According to Caryn James, DiCaprio is unafraid of working with established directors on unconventional projects; taking such risks has led him to star in failed films like The Beach (2000), but also his successful collaborations with Martin Scorsese. DiCaprio has described his relationship with Scorsese as dreamlike and admires his knowledge of film, crediting the director with having taught him its history and importance. Scorsese has commented on DiCaprio's ability to repeatedly demonstrate emotion on screen. Jesse Hassenger of The A.V.
== Differential diagnosis == The symptoms of Morvan's Syndrome have been noted to bear a striking similarity to limbic encephalitis (LE). These include the CNS symptoms consisting of insomnia, hallucinations, and disorientation, as well as dementia and psychosis. Both entities can be paraneoplastic and associated with thymoma. Recently, VGKC antibodies were found in patients with LE, strengthening the hypothesis that LE and Morvan's Syndrome may be closely connected. Varying symptoms may be used to determine which of the two diseases the subject has. Amnesia, seizures, and mesial temporal lobe structural abnormalities are features of LE, whereas myokymia, hyperhydrosis, and insomnia favor Morvan's Syndrome.
== B == Baeyer–Drewsen indigo synthesis (also commonly incorrectly named Baeyer–Drewson indigo synthesis) Baeyer–Villiger oxidation, Baeyer–Villiger rearrangement Bakeland process (Bakelite) Baker–Venkataraman rearrangement, Baker–Venkataraman transformation Baldwin's rules Bally–Scholl synthesis Balz–Schiemann reaction Bamberger rearrangement Bamberger triazine synthesis Bamford–Stevens reaction Barbier reaction Barbier–Wieland degradation Bardhan–Sengupta phenanthrene synthesis Barfoed's test Bargellini reaction Bartoli indole synthesis, Bartoli reaction Barton decarboxylation Barton reaction Barton–Kellogg reaction Barton–McCombie reaction, Barton deoxygenation Barton-Zard Synthesis Barton vinyl iodine procedure Baudisch reaction Bayer test Baylis–Hillman reaction Bechamp reaction Bechamp reduction Beckmann fragmentation Beckmann rearrangement Bellus–Claisen rearrangement Belousov–Zhabotinsky reaction Benary reaction Benedict's reagent Benkeser reaction Benzidine rearrangement Benzilic acid rearrangement Benzoin condensation Bergman cyclization Bergmann azlactone peptide synthesis Bergmann degradation Bergmann–Zervas carbobenzoxy method Bernthsen acridine synthesis Bestmann's reagent Betti reaction Biginelli pyrimidine synthesis Biginelli reaction Bingel reaction Birch reduction Bischler–Möhlau indole synthesis Bischler–Napieralski reaction Biuret test Blaise ketone synthesis Blaise reaction Blanc reaction Blanc chloromethylation Blum–Ittah aziridine synthesis Bodroux reaction Bodroux–Chichibabin aldehyde synthesis Bogert–Cook synthesis Bohlmann-Rahtz pyridine synthesis Bohn–Schmidt reaction Boord olefin synthesis Borodin reaction Borsche–Drechsel cyclization Bosch–Meiser urea process Bosch reaction Bouveault aldehyde synthesis Bouveault–Blanc reduction Boyland–Sims oxidation Boyer Reaction Bredt's rule Brook rearrangement Brown hydroboration Bucherer carbazole synthesis Bucherer reaction Bucherer–Bergs reaction Buchner ring enlargement Büchner–Curtius–Schlotterbeck reaction Buchwald–Hartwig amination Bunnett reaction Burgess reagent
Sources: en.wikipedia.org
No regulatory agency has authorised melanotan-2 as a medicine for any indication. It circulates mainly as a research chemical or through unregulated channels. As a result, identity, purity and content are not independently guaranteed.
Melanotan-1, also called afamelanotide, is a linear analogue with greater selectivity for MC1R and has received approval in some jurisdictions for a specific photosensitivity disorder. Melanotan-2 is cyclic, less selective, and reaches central receptors more readily. The two are often confused in online discussion despite different pharmacology and regulatory status.
Alpha-MSH is an endogenous tridecapeptide derived from pro-opiomelanocortin. Melanotan-2 reproduces its core receptor-binding sequence inside a shortened, stabilised ring. The result is a molecule with a longer effective half-life and higher potency than the parent hormone.
Laboratory confirmation typically combines retention time matching on a chromatographic system with mass measurement. A reference standard of known identity is needed for a meaningful comparison. Sequence-level techniques can add further confirmation.